On the public citation graph

EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?

https://doi.org/10.1007/s00125-017-4264-9
0 signed · 135 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/hep.21496openalex-snapshot
The NAFLD fibrosis score
inferredcites →https://doi.org/10.1002/hep.25762openalex-snapshot
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
inferredcites →https://doi.org/10.1002/hep.27368openalex-snapshot
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
inferredcites →https://doi.org/10.1002/hep.28431openalex-snapshot
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
inferredcites →https://doi.org/10.1002/hep.29085openalex-snapshot
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
inferredcites →https://doi.org/10.1007/s00125-016-3902-yopenalex-snapshot
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1007/s11695-016-2123-2openalex-snapshot
Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency
inferredcites →https://doi.org/10.1007/s11695-016-2246-5openalex-snapshot
Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese
inferredcites →https://doi.org/10.1016/j.jhep.2015.11.004openalex-snapshot
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1053/j.gastro.2015.04.043openalex-snapshot
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1111/dme.13565openalex-snapshot
European Association for the Study of the Liver ( EASL ), European Association for the Study of Diabetes ( EASD ) and European Association for the Study of Obesity ( EASO ) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in…
inferredcites →https://doi.org/10.1111/liv.13299openalex-snapshot
The epidemiology of non‐alcoholic fatty liver disease

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.5281/zenodo.3708526openalex-extracted
Non-Alcoholic Fatty Liver Disease and its Interplay with Various Metabolic Disorders
inferred← citeshttps://doi.org/10.1002/jbt.22914openalex-snapshot
Omarigliptin protects against nonalcoholic fatty liver disease by ameliorating oxidative stress and inflammation
inferred← citeshttps://doi.org/10.1007/978-3-030-47336-5_2openalex-snapshot
Obesity-Induced Cardiovascular Complications and Therapeutic Intervention
inferred← citeshttps://doi.org/10.1007/978-3-030-62632-7_9openalex-snapshot
Nutraceuticals for Non-alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s00330-020-07235-4openalex-snapshot
Whole-liver histogram and texture analysis on T1 maps improves the risk stratification of advanced fibrosis in NAFLD
inferred← citeshttps://doi.org/10.1007/s11428-020-00649-0openalex-snapshot
Nichtalkoholische Fettlebererkrankung und Typ‑2‑Diabetes
inferred← citeshttps://doi.org/10.1007/s11695-016-2246-5openalex-snapshot
Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese
inferred← citeshttps://doi.org/10.1007/s11695-021-05885-xopenalex-snapshot
Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States
inferred← citeshttps://doi.org/10.1007/s11901-019-00497-7openalex-snapshot
Should We Screen High-Risk Populations for NAFLD?
inferred← citeshttps://doi.org/10.1007/s40618-020-01188-7openalex-snapshot
Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD
inferred← citeshttps://doi.org/10.1016/b978-2-294-76753-1.00114-4openalex-snapshot
Phénotypage clinique et personnalisation de la médecine des obésités
inferred← citeshttps://doi.org/10.1016/j.cgh.2017.10.037openalex-snapshot
Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease
inferred← citeshttps://doi.org/10.1016/j.cgh.2019.04.038openalex-snapshot
Risk Factors for Severe Liver Disease in Patients With Type 2 Diabetes
inferred← citeshttps://doi.org/10.1016/j.clinre.2024.102389openalex-snapshot
Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population
inferred← citeshttps://doi.org/10.1016/j.clinthera.2021.07.013openalex-snapshot
Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.diabres.2021.108882openalex-snapshot
Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective study
inferred← citeshttps://doi.org/10.1016/j.dld.2018.03.029openalex-snapshot
Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society
inferred← citeshttps://doi.org/10.1016/j.dsx.2019.07.019openalex-snapshot
Adherence to a healthy plant diet may reduce inflammatory factors in obese and overweight women-a cross-sectional study
inferred← citeshttps://doi.org/10.1016/j.ejphar.2018.08.040openalex-snapshot
Sparstolonin B (SsnB) attenuates liver fibrosis via a parallel conjugate pathway involving P53-P21 axis, TGF-beta signaling and focal adhesion that is TLR4 dependent
inferred← citeshttps://doi.org/10.1016/j.ejphar.2020.172913openalex-snapshot
Challenges and opportunities in drug development for nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e20642openalex-snapshot
Accuracy of attenuation coefficient measurement (ACM) for real-time ultrasound hepatic steatometry: Comparison of simulator/phantom data with magnetic resonance imaging proton density fat fraction (MRI-PDFF)
inferred← citeshttps://doi.org/10.1016/j.jcmgh.2018.07.004openalex-snapshot
Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis
inferred← citeshttps://doi.org/10.1016/j.jhep.2019.08.027openalex-snapshot
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
inferred← citeshttps://doi.org/10.1016/j.livres.2021.03.004openalex-snapshot
Vitamins and non-alcoholic fatty liver disease: A molecular insight
inferred← citeshttps://doi.org/10.1016/j.metabol.2020.154299openalex-snapshot
Metabolic liver disease in diabetes – From mechanisms to clinical trials
inferred← citeshttps://doi.org/10.1016/j.numecd.2019.08.001openalex-snapshot
Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD
inferred← citeshttps://doi.org/10.1016/j.nupar.2019.12.005openalex-snapshot
La stéatopathie dysmétabolique ou NASH : faut-il dépister les patients à haut risque atteints de diabète de type 2 ou d’obésité ?
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2019.107401openalex-snapshot
The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.phrs.2018.07.014openalex-snapshot
Future trends in the treatment of non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.rgmx.2018.11.007openalex-snapshot
Consenso mexicano de la enfermedad por hígado graso no alcohólico
inferred← citeshttps://doi.org/10.1016/j.rgmxen.2019.02.003openalex-snapshot
The Mexican consensus on nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.steroids.2023.109330openalex-snapshot
Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style
inferred← citeshttps://doi.org/10.1016/j.xjidi.2025.100419openalex-snapshot
High Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Hidradenitis Suppurativa: A Guide to Easily Assess the Clinical Risk of Comorbid Liver Disease
inferred← citeshttps://doi.org/10.1038/s41387-022-00182-7openalex-snapshot
Metabolic biomarkers related to cardiac dysfunction in metabolic-dysfunction-associated fatty liver disease: a cross-sectional analysis
inferred← citeshttps://doi.org/10.1038/s41467-019-09455-9openalex-snapshot
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1038/s41574-023-00898-1openalex-snapshot
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1038/s41588-022-01199-5openalex-snapshot
Multiomics study of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1038/s41598-020-59535-wopenalex-snapshot
A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD
inferred← citeshttps://doi.org/10.1038/s41598-020-75227-xopenalex-snapshot
Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination
inferred← citeshttps://doi.org/10.1038/s41598-024-53112-1openalex-snapshot
Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
inferred← citeshttps://doi.org/10.1055/a-2149-7976openalex-snapshot
Neues zur Fettleber: Nomenklatur, Screening-Empfehlungen, Therapiebemühungen und andere klinisch relevante Aspekte
inferred← citeshttps://doi.org/10.1055/s-0041-1725022openalex-snapshot
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms
inferred← citeshttps://doi.org/10.1080/17474124.2021.1974295openalex-snapshot
Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review
inferred← citeshttps://doi.org/10.1080/17474124.2023.2172397openalex-snapshot
Comparative efficacy of glucagon-like peptide 1 (GLP-1) receptor agonists, pioglitazone and vitamin E for liver histology among patients with nonalcoholic fatty liver disease: systematic review and pilot network meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1097/med.0000000000000464openalex-snapshot
Dyslipidemia in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1097/meg.0000000000001882openalex-snapshot
A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis
inferred← citeshttps://doi.org/10.1111/1753-0407.13134openalex-snapshot
Association between nonalcoholic fatty liver and increased low‐level albuminuria in postmenopausal women in China: A cross‐sectional study
inferred← citeshttps://doi.org/10.1111/apt.14529openalex-snapshot
Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement
inferred← citeshttps://doi.org/10.1111/apt.14632openalex-snapshot
Editorial: the impact of steatosis on liver stiffness quantification is minimal—Authors’ reply
inferred← citeshttps://doi.org/10.1111/dme.13565openalex-snapshot
European Association for the Study of the Liver ( EASL ), European Association for the Study of Diabetes ( EASD ) and European Association for the Study of Obesity ( EASO ) clinical practice recommendations for the management of non‐alcoholic fatty liver disease: evaluation of their application in…
inferred← citeshttps://doi.org/10.1111/jgh.15482openalex-snapshot
Systematic review: Accuracy of the enhanced liver fibrosis test for diagnosing advanced liver fibrosis and cirrhosis
inferred← citeshttps://doi.org/10.1111/joim.13570openalex-snapshot
Unrecognized liver cirrhosis is common and associated with worse survival in hepatocellular carcinoma: A nationwide cohort study of 3473 patients
inferred← citeshttps://doi.org/10.1111/liv.15437openalex-snapshot
The impact of fatigue on mortality of patients with non‐alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005–2010 and 2017–2018
inferred← citeshttps://doi.org/10.11569/wcjd.v28.i11.393openalex-snapshot
Application prospects of glucagon-like peptide-1 receptor agonists in treatment of metabolic diseases
inferred← citeshttps://doi.org/10.1186/s12876-021-02038-3openalex-snapshot
FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran
inferred← citeshttps://doi.org/10.1186/s12911-023-02402-1openalex-snapshot
Gut microbiome-based machine learning for diagnostic prediction of liver fibrosis and cirrhosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s12986-024-00784-1openalex-snapshot
Glutamine prevents high-fat diet-induced hepatic lipid accumulation in mice by modulating lipolysis and oxidative stress
inferred← citeshttps://doi.org/10.1210/jc.2018-02792openalex-snapshot
Diet-Dependent Acid Load—The Missing Link Between an Animal Protein–Rich Diet and Nonalcoholic Fatty Liver Disease?
inferred← citeshttps://doi.org/10.12659/msm.911062openalex-snapshot
Efficacy and Clinical Value of Liraglutide for Treatment of Diabetes Mellitus Complicated by Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.12677/acm.2023.1381788openalex-snapshot
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Clinical Evidence and a Mechanistic Review
inferred← citeshttps://doi.org/10.12816/0044663openalex-snapshot
Systemic Review : Role of Lifestyle Interventions for the Treatment of Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0307500openalex-snapshot
Derivation and validation of the BIMAST score for predicting the presence of fibrosis due to Metabolic dysfunction-associated steatotic liver disease among diabetic patients in the community
inferred← citeshttps://doi.org/10.14218/jtg.2023.00071openalex-snapshot
Liver Fibrosis as an Independent Cardiovascular Risk Factor in Non-alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.15403/jgld-415openalex-snapshot
Combination of non-invasive fibrosis tests: a solution for the prediction of advanced fibrosis in non-alcoholic fatty liver disease?
inferred← citeshttps://doi.org/10.1556/650.2018.31231openalex-snapshot
Nem alkoholos zsírmájbetegség – a 2016. évi közös EASL–EASD–EASO klinikai ajánlás fényében
inferred← citeshttps://doi.org/10.1900/rds.2022.18.140openalex-snapshot
Prevalence and Specific Manifestations of Non-alcoholic Fatty Liver Disease (NAFLD) and Diabetes Mellitus Type 2 Association in a Moroccan Population: A Cross-sectional Study
inferred← citeshttps://doi.org/10.20517/2394-5079.2021.03openalex-snapshot
Systematic review of existing guidelines for NAFLD assessment
inferred← citeshttps://doi.org/10.20944/preprints202008.0417.v1openalex-snapshot
FIB-4 First in Diagnostic Algorithm of MAFLD at the Era of “Global Metabodemic “
inferred← citeshttps://doi.org/10.21037/qims-24-555openalex-snapshot
Multi-echo three-dimensional (3D) Dixon sequence combined with disodium gadolinium for risk stratification of advanced fibrosis in metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2135338/v1openalex-snapshot
Clinical and cost-effectiveness analysis of community-based screening strategies for non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3493430/v1openalex-snapshot
Associations among albumin-bilirubin grade, metabolic dysfunction-associated fatty liver disease, and exercise
inferred← citeshttps://doi.org/10.2147/dmso.s555108openalex-snapshot
Elevated LECT2 and PEDF in Pediatric MAFLD: Diagnostic Performance and Metabolic Correlations
inferred← citeshttps://doi.org/10.2174/0118715303230418230925060312openalex-snapshot
Global Trends of Treatment for NAFLD from 2012 to 2021: A Bibliometric and Mapping Analysis
inferred← citeshttps://doi.org/10.2196/82529openalex-snapshot
Hepatic Steatosis Severity Prediction in Nonobese Individuals: Machine Learning Model Development and Validation
inferred← citeshttps://doi.org/10.22141/2224-0721.20.1.2024.1353openalex-snapshot
Features of type 2 diabetes combined with metabolic dysfunction-associated fatty liver disease under conditions of chronic stress
inferred← citeshttps://doi.org/10.23736/s0026-4806.21.07527-3openalex-snapshot
Gut microbiota and cardiovascular diseases axis
inferred← citeshttps://doi.org/10.24018/ejmed.2021.3.4.941openalex-snapshot
MAFLD-Epidemiology, Natural History, Outcomes and Prevention
inferred← citeshttps://doi.org/10.29254/2077-4214-2021-3-161-153-157openalex-snapshot
FREQUENCY OF THE LIVER INJURY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ACCORDING TO THE RESULTS OF NON-INVASIVE METHODS OF RESEARCH
inferred← citeshttps://doi.org/10.30978/cees-2023-3-62openalex-snapshot
Diagnosis and treatment of metabolic-associated fatty liver disease in patients with type 2 diabetes mellitus. Review
inferred← citeshttps://doi.org/10.3389/fendo.2019.00033openalex-snapshot
Interventions to Address Environmental Metabolism-Disrupting Chemicals: Changing the Narrative to Empower Action to Restore Metabolic Health
inferred← citeshttps://doi.org/10.3390/biomedicines10030524openalex-snapshot
The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
inferred← citeshttps://doi.org/10.3390/biomedicines10051015openalex-snapshot
Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis
inferred← citeshttps://doi.org/10.3390/biomedicines10102416openalex-snapshot
Waist-to-Hip Ratio and Inflammatory Parameters Are Associated with Risk of Non-Alcoholic Fatty Liver Disease in Patients with Morbid Obesity
inferred← citeshttps://doi.org/10.3390/cancers13153740openalex-snapshot
The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/diseases6030080openalex-snapshot
Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD
inferred← citeshttps://doi.org/10.3390/diseases6040086openalex-snapshot
The Role of Vitamin E in the Treatment of NAFLD
inferred← citeshttps://doi.org/10.3390/diseases7010027openalex-snapshot
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
inferred← citeshttps://doi.org/10.3390/genes10030184openalex-snapshot
iNOS Gene Ablation Prevents Liver Fibrosis in Leptin-Deficient ob/ob Mice
inferred← citeshttps://doi.org/10.3390/ijms25094916openalex-snapshot
Supplementation of Micro- and Macronutrients—A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/jcm10030404openalex-snapshot
Referral Patterns for Patients with Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/jcm10050930openalex-snapshot
The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients
inferred← citeshttps://doi.org/10.3390/jcm10061161openalex-snapshot
Natural History of NAFLD
inferred← citeshttps://doi.org/10.3390/jcm10143029openalex-snapshot
Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.3390/jcm12175597openalex-snapshot
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
inferred← citeshttps://doi.org/10.3390/jcm13133893openalex-snapshot
Ramadan Fasting in Individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Transplant, and Bariatric Surgery: A Narrative Review
inferred← citeshttps://doi.org/10.3390/jcm14061841openalex-snapshot
Ramadan Fasting and Complications of Metabolic Dysfunction-Associated Steatotic Liver Disease: Impacts on Liver Cirrhosis and Heart Failure
inferred← citeshttps://doi.org/10.3390/jcm9051369openalex-snapshot
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
inferred← citeshttps://doi.org/10.3390/life11020143openalex-snapshot
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
inferred← citeshttps://doi.org/10.3390/life15111764openalex-snapshot
The Vicious Circle of Metabolic Dysfunction-Associated Steatotic Liver Disease When Micronutrient Deficiency Drives Microbial Imbalance and Liver Injury
inferred← citeshttps://doi.org/10.3390/medicina57050434openalex-snapshot
The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on COVID-19 Disease Prognosis
inferred← citeshttps://doi.org/10.3390/metabo11060374openalex-snapshot
Metabolomic Study of High-Fat Diet-Induced Obese (DIO) and DIO Plus CCl4-Induced NASH Mice and the Effect of Obeticholic Acid
inferred← citeshttps://doi.org/10.3390/nu10091135openalex-snapshot
Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases
inferred← citeshttps://doi.org/10.3390/nu11122971openalex-snapshot
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered
inferred← citeshttps://doi.org/10.3390/nu14010103openalex-snapshot
Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
inferred← citeshttps://doi.org/10.3390/nu14214505openalex-snapshot
Dietary Quality and Relationships with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) among United States Adults, Results from NHANES 2017–2018
inferred← citeshttps://doi.org/10.3390/nu17142331openalex-snapshot
Lifestyle Intervention Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Children with Down Syndrome
inferred← citeshttps://doi.org/10.3390/v15081730openalex-snapshot
Non-Invasive Measurement of Hepatic Fibrosis by Transient Elastography: A Narrative Review
inferred← citeshttps://doi.org/10.3410/f.735422910.793558925openalex-snapshot
Faculty Opinions recommendation of A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease.
inferred← citeshttps://doi.org/10.3748/wjg.v27.i35.5803openalex-snapshot
Screening for nonalcoholic fatty liver disease-when, who and how?
inferred← citeshttps://doi.org/10.4236/fns.2023.143017openalex-snapshot
A Review on the Role of Low Glycemic Index Foods for Glycemic Control in Chronic Liver Disease
inferred← citeshttps://doi.org/10.4236/ijcm.2019.104019openalex-snapshot
Progress in Research on Nonalcoholic Fatty Liver and Gestational Diabetes
inferred← citeshttps://doi.org/10.4236/ojemd.2025.158014openalex-snapshot
Risk Factors for Liver Fibrosis in Patients with Type 2 Diabetes Mellitus and Metabolic Dysfunction–Associated Steatotic Liver Disease in Brazzaville
inferred← citeshttps://doi.org/10.47102/annals-acadmedsg.2022284openalex-snapshot
Non-alcoholic fatty liver disease screening in type 2 diabetes mellitus: A cost-effectiveness and price threshold analysis
inferred← citeshttps://doi.org/10.5005/jp-journals-10018-1359openalex-snapshot
Holistic Approach in the Management of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.5114/pg.2019.88165openalex-snapshot
Non-alcoholic fatty liver disease in Poland: how and at what stage is diagnosed, and how is treated. A survey study
inferred← citeshttps://doi.org/10.51168/sjhrafrica.v4i12.761openalex-snapshot
CORRELATION OF FIB-4 AND APRI SCORE WITH FIBRO SCAN SCORE TO PREDICT FIBROSIS IN OBESE TYPE-2 DIABETIC PATIENTS.
inferred← citeshttps://doi.org/10.51985/jbumdc2023227openalex-snapshot
Preventing NASH with Empagliflozin and Linagliptin: A Diabetic Drug Combination
inferred← citeshttps://doi.org/10.5603/dk.2020.0036openalex-snapshot
Hepatic steatosis indices as predictors of vitamin D3 deficiency in patients with NAFLD associated with type 2 diabetes
inferred← citeshttps://doi.org/10.5772/intechopen.85780openalex-snapshot
The Rise in the Prevalence of Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.6084/m9.figshare.24873066openalex-snapshot
Additional file 1 of Gut microbiome-based machine learning for diagnostic prediction of liver fibrosis and cirrhosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.24873179openalex-snapshot
Additional file 2 of Gut microbiome-based machine learning for diagnostic prediction of liver fibrosis and cirrhosis: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.6084/m9.figshare.26691004openalex-snapshot
Additional file 1 of Glutamine prevents high-fat diet-induced hepatic lipid accumulation in mice by modulating lipolysis and oxidative stress
inferred← citeshttps://doi.org/10.70675/8139d5c7zb3b1z466az837az2b9408b374a8openalex-snapshot
Rôle des cellules endothéliales dans le carcinome hépatocellulaire associé au syndrome métabolique
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.